These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21320089)

  • 1. Allergy to low dose sugammadex.
    Menéndez-Ozcoidi L; Ortiz-Gómez JR; Olaguibel-Ribero JM; Salvador-Bravo MJ
    Anaesthesia; 2011 Mar; 66(3):217-9. PubMed ID: 21320089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersensitivity reaction probably induced by sugammadex.
    Asahi Y; Omichi S; Adachi S; Kagamiuchi H; Kotani J
    Acta Anaesthesiol Taiwan; 2012 Dec; 50(4):183-4. PubMed ID: 23385042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three cases of suspected sugammadex-induced hypersensitivity reactions.
    Godai K; Hasegawa-Moriyama M; Kuniyoshi T; Kakoi T; Ikoma K; Isowaki S; Matsunaga A; Kanmura Y
    Br J Anaesth; 2012 Aug; 109(2):216-8. PubMed ID: 22617091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
    Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK
    Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can sugammadex save a patient in a simulated 'cannot intubate, cannot ventilate' situation?
    Bisschops MM; Holleman C; Huitink JM
    Anaesthesia; 2010 Sep; 65(9):936-41. PubMed ID: 21198485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial.
    Pühringer FK; Rex C; Sielenkämper AW; Claudius C; Larsen PB; Prins ME; Eikermann M; Khuenl-Brady KS
    Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sugammadex hypersensitivity-a case of anaphylaxis.
    Jeyadoss J; Kuruppu P; Nanjappa N; Van Wijk R
    Anaesth Intensive Care; 2014 Jan; 42(1):89-92. PubMed ID: 24471668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients.
    McDonagh DL; Benedict PE; Kovac AL; Drover DR; Brister NW; Morte JB; Monk TG
    Anesthesiology; 2011 Feb; 114(2):318-29. PubMed ID: 21239968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three suspected cases of sugammadex-induced anaphylactic shock.
    Takazawa T; Tomita Y; Yoshida N; Tomioka A; Horiuchi T; Nagata C; Orihara M; Yamada MH; Saito S
    BMC Anesthesiol; 2014; 14():92. PubMed ID: 25349529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Case of anaphylactic reaction caused by sugammadex].
    Motoyama Y; Izuta S; Maekawa N; Chuma R
    Masui; 2012 Jul; 61(7):746-8. PubMed ID: 22860305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugammadex: the first selective binding reversal agent for neuromuscular block.
    Kovac AL
    J Clin Anesth; 2009 Sep; 21(6):444-53. PubMed ID: 19833281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of sugammadex in a patient with myasthenia gravis.
    Unterbuchner C; Fink H; Blobner M
    Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sugammadex: a selective relaxant-binding agent providing rapid reversal.
    Rex C; Bergner UA; Pühringer FK
    Curr Opin Anaesthesiol; 2010 Aug; 23(4):461-5. PubMed ID: 20489603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of anaphylaxis apparently induced by sugammadex and rocuronium in successive surgeries.
    Yamada Y; Yamamoto T; Tanabe K; Fukuoka N; Takenaka M; Iida H
    J Clin Anesth; 2016 Aug; 32():30-2. PubMed ID: 27290941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sugammadex in anesthesia practice.
    Duvaldestin P; Plaud B
    Expert Opin Pharmacother; 2010 Nov; 11(16):2759-71. PubMed ID: 20977408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sugammadex: a new approach to muscle relaxation and its reversal].
    Duvaldestin P
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S39-40. PubMed ID: 19887275
    [No Abstract]   [Full Text] [Related]  

  • 19. The First Case Report of Anaphylaxis Caused by the Inclusion Complex of Rocuronium and Sugammadex.
    Ho G; Clarke RC; Sadleir PH; Platt PR
    A A Case Rep; 2016 Nov; 7(9):190-192. PubMed ID: 27552242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.